Ticker: BBIO

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has recently released its financial performance for the second quarter of 2025, highlighting significant movements in its income statement. Key Highlights: Total revenues: Increased dramatically to $110.6 million in Q2 2025 from $2.2 million in Q2 2024, prim...